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Sa_y EEkven survivors of pelvic rhabdomyosarcoma underwent bladduer function studies and upper
urnary tract evaluation at a mean of 6.6 years after completion of therapy, which induded a conservative,
bladder-spang surgial polcy. Pnmary tumour sites were: bladder base/prostate, 6; bladder dome, 1; vagina,
2; and pelc side wall, 2. Seven chidren (five bladder base/prostate, one vagna and one pelvic side wall
tumours) had receivd irradiation to the pehlis with extenal beam alone, brachytherapy or both. Al seven of
these patients had markedly reduced functional badder capacity (11-48% of mean expected value for age)
and abnormal voiding patters, though bladder complance was not reduced and bladder emptying was almost
complete in five cases. Four of these chidren also had upper tract dilatation and two required reconstructive
bladder surgery because of severe bilateral hydronephrosis. By contrast, each of four childr treated without
radiotherapy had a normal functional bladder capacity and a normal voiding pattern. All survivors of pelvic
rhabdomyosarcoma, especially those who have received radiotherapy, should be carefully monitored for
dysfunction of both lower and upper urinary tracts. The frequency-volume voiding chart is a sensitive and
easily accomphshd method of assessing bladder fution in these patients.
With the advent of multidisciplinary therapy over the past
two decades, there have been major advances in the manage-
ment of children with pelvic rhabdomyosarcoma (RMS).
Overall 3 year survival rates of 70-78% have been reported
(Maurer et al., 1988; Raney et al., 1990). The challenge now
is to find a suitable combination of treatment modalities that
will maintain this high cure rate with a minimum of mor-
bidity - 'cure at least cost'. Preservation of pelvic organs,
especially the urinary bladder and the vagina, has become
one of the main goals of modern treatment (Ortega et al.,
1979; Voute et al., 1981; Massad et al., 1991).
The survival of 20 childrn with pelvic RMS treated
between 1976 and 1983 in our hospital with chemotherapy,
radiotherapy and radical surgery was 55%, and only 6 of the
11 survivors retained their bladders (Broecker et al., 1988).
Despite these disappointing results we decided, in 1983, to
adopt a more conservative surgical policy. After initial inten-
sive chemotherapy, local removal of tumour was undertaken
with a view to preserving the bladder. Patients with com-
pletely resected tumours received only chemotherapy post-
operatively, whereas those with residual disease were treated
by combined chemotherapy and radiotherapy (Atra et al.,
1994). The purpose of this study was to evaluate the long-
term function of the retained bladders in surviving patients
and to assess whether this treatment approach had any
adverse effects on the upper urinary tract.
Patie.s and mthod
Between 1983 and 1988, 26 children with newly diagnosed
primary pelvic RMS (excluding those with paratestiular
tumours) were treated in our institution. Treatment was with
intensive chemotherapy (pulsed vincristine, actinomycin D
and either cyclophosphamide or iphosphamide, i.e. 'VAC' or
'IVA') and, whenever possible, conservative bladder-sparing
surgery. Radiation therapy (external beam, brachytherapy or
both) was used for non-resectable or incompletely resected
tumours. Full details are provided elsewhere (Atra et al.,
1994). Surgical procedures were (a) partial cystectomy, (b)
submucosal resection of residual tumour or (c) resection of
exophytic paravesical masses. Total cystectomy or cystopro-
statectomy were carried out only after proven localised
tumour recurrence.
Nineteen (73%) of the 26 children survived, and the 17
who retained their bladders formed the basis of this study.
The following investigations were carried out: (a) a micturi-
tion frequency-volume chart completed at home for a mini-
mum of 5 days to record the volumes and frequency of fluid
intake and urine output as well as leakage; (b) an ultrasound
scan of the urinary tract; (c) a 9Tc-mercaptoacetyltriglycine
(MAG3) isotope renogram; and (d) an indirect isotope cysto-
gram. Children with an abnormal voiding pattern according
to the frequency-volume chart also underwent a conven-
tional urodynamic study using a Gaeltec GR700 urodynamic
system (Gaeltec Research, UK). This was performed through
a double-lumen IOF suprapubic catheter inserted under
general anaesthesia 24 h prior to the study. A catheter was
placed in the rectum for recording the abdominal pressure
just before the commencement of the study. Bladder filling
was with room temperature normal saline at a rate of
10-15 ml min-'. The filling volume, together with the intra-
vesicaL abdominal and detrusor pressures, were recorded
continuously during both filling and micturition phases.
The functional blader capacity of each child was assmssed
using the maximum voided volumes from the frequency-
volume chart. The actual capacity was then compared with
the expected bladder capacity according to age, calculated
using the formula (Koff, 1983):
bladder capacity (ml) = [age (years) + 2] x 30
Informed consent for all these studies was obtained from
the children's parents and, for children of appropriate age,
from the patients thelmlves. The chi-square test with Yates's
correction was used for statistical comparisons, with P-values
of <0.05 taken as significant.
Re ts (Table 1)
Of the 17 children eligible for the study, four lived abroad
and were not available for study and two declined to par-
ticipate. In the 11 chkldren (five boys) recruited into the
study, the primary tumour sites were bladder base/prostate in
six, pelvic wall in two, vagina in two and bladder dome in
one. Histological subtypes were embryonal in ten and
alveolar in one case. The proportions were similar to those in
the whole group of 17 patients. Two children completed the
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frequency-volume chart but, having no clinical problems,
did not wish to proceed with further investigations. Nime
completed the planned studies. Their ages ranged from 6 to
16 years (mean 10.8 years), at a mean follow-up of 6.6 years
(range 4-9.5 years) after completion of all treatment for their
sarcomas.
Four of the 11 children who were studied had a normal
voiding pattern. Seven children had an abnormal voiding
pattern. Three of them were constantly wet both by day and
by night; one was a boy who also had continuous dribbling
of urine via a rectourethral fistula. The other four children
were continent by day but had nocturnal enuresis. One of
them, a 15-year-old girL, also had very frequent, small-
volume voiding during the daytime. Assessment of functional
bladder capacity using the frequency-volume chart was pos-
sible in ten children (Table I), but not in the boy with a
rectourethral fistula. Six children had reduced functional
bladder capacity with between 11% and 48% (median 22%)
of expected bladder capacity for age. All six of these child-
ren, and the boy with a rectourethral fistula, had abnormal
voiding patterns varying in severity from nocturnal enuresis
only to continuous dribbling of urine by day and by night.
Each of these seven children had received post-operative
extemal beam pelvic iradiation with doses from 3,000 to
5,000cGy; three of them (patients 3, 4 and 5) had also
received brachytherapy. By contrast, none of the four child-
ren with a normal functional bladder capacity (range
91-126%; median 103%) and a normal voiding pattern had
received radiotherapy (P<0.01). No obvious correlation was
observed between functional bladder capacity and (i) the site
of origin of the primary tumour, (ii) the type of surgical
operation; (iii) the amount of bladder removed during the
tumour resection; or (iv) the cumulative dose of iphos-
phamide or cyclophosphamide.
Of the nine childrn who finished the entire series of
planned investigations, the ultrasound scan showed normal
findings in five patients. Two chiklrn had mild to moderate
unilateral hydronephrosis and two had severe bilateral
hydronephrosis. The isotope renogram also showed normal
findings in five patients; two children had mild unilateral
impairment of kidney fumction and the other two had
marked bilateral impairment of function. Indirect isotope
cystography revealed mild unilateral vesicoureteric reflux
(VUR) in one child and gross bilateral VUR in two children.
The other six patients had no reflux. Abnormal imaging
findings were detected only in children who had received
radiotherapy (Table I).
Urodynamic studies were performed in four of the seven
children with abnormal voiding patterns, and reduced func-
tional bladder capacity was confirmed in each instance. None
of these children had detrusor instability. Maximal detrusor
presu during voiding ranged from 38 to 66 cm H20 with a
peak uine flow rate of 14-27 ml s-'. All had complete blad-
der emptying. Decreased bladder compliance, as indicated by
a high end-filling pressure of over 20cm H20, was found
only in one boy with a bladder base tumour (patient 3). He
was also found to have a very low bladder capacity of 14%
of normal mean for age.
Both patients with severe bilateral hydronephrosis and
impaired renal function have subsequently undergone recon-
structive surgery in the form of augmentation ilecystoplasty
with bladder neck reconstruction and an appendiceal Mitro-
fanoff stoma. One boy (patient 4) with a bladder base tumour,
who had received radiotherapy, developed recurrent bladduer
stones and required cystolithotripsy. The boy with a rec-
tourethral fistula and another girl (patient 2) are currently
awaiting reconstructive surgery.
Discossim
Contrasting results have been reported from different centres
adopting a primary chemotherapy-bladder preservation
strategy for pelvic RMS. The Second United States Inter-
group Rhabdomyosarcoma Study (IRS-II) has reported a
disappointing 3 year disease-free survival (DFS) rate of 52%,
significantly inferior (P = 0.02) to the 70% DFS achieved in
the IRS-I study in which radical primary surgery was used.
Another disappointment was that in IRS-II only 22% of
patients with bladder/prostate primary tumours retained their
bladders at 3 years, an outcome similar to that of IRS-I
(23% with preserved bladders) (Maurer et al., 1988; Raney et
al., 1990). Similar figures had also been reported by Grosfeld
(1983) and McLorie (1989), who concluded that bladder
salvage, although desirable, is possible only in the complete
absnce of residual disease after chemoradiotherapy (Gros-
feld et al., 1983; McLorie et al., 1989).
More encouraging results have been reported from other
centres. Ghavimi et al. (1984) for instance, reported a 50%
bladder salvage rate among 18 survivors, and Pratt et al.
(1984) have reported a 73% survival and 81% bladder sal-
vage rate. However, very few reports even mention the func-
tional status of the bladders or the upper urinary tracts
(Ortega, 1979; Voute et al., 1981; Hays et al., 1982, 1990;
Grosfeld et al., 1983; Ghavimi et al., 1984; Pratt, 1984;
Maurer et al., 1988; McLorie et al., 1989; Crist et al., 1990;
Raney et al., 1990; La Quaglia, 1991; Massad et al., 1991)
and to our knowledge no detailed studies, such as this one,
have been published.
Although the numbers in our study are small, the overall 3
year survival rate of 73% and bladder salvage rate, in our
survivors, of 89% compare favourably with other reported
series (Ortega, 1979; Voute et al., 1981; Grosfeld et al., 1983;
Koff, 1983; Ghavimi et al., 1984; Pratt, 1984; Maurer et al.,
1988; McClorie et al., 1989; Crist et al., 1990; La Quaglia et
al., 1990; Raney et al., 1990; La Quaglia, 1991; Massad et al.,
1991). The high bladder salvage rate is the consequence of(a)
our policy of treating local residual disease with irradiation
rather than radical surgery, unless there was unequivocal
persistent tumour-, (b) during serial endoscopic follow-up,
cautious interpretation of'positive' histopathological reports
on biopsies taken from the site of previous tumour-bearing
areas that appear macroscopically normal (Atra et al., 1994);
and (c) cautious interpretation of follow-up pelvic com-
puterised tomographic (Cr) scans (Atra et al., 1994). The
surgical expertise available in our institute for successful
excision of residual tumours in the bladder base, using the
submucosal resection technique without resorting to total
cystourethrectomy, and for any subsequent urinary tract re-
construction is also a crucial part of this bladder conserva-
tion policy.
Early local irradiation has been advocated by Tefft et al.
(1980) for patients with residual disease and involvement of
regional nodes. We do not dissect the internal iliac nodes in
our patients and we have achieved good 'local tumour con-
trol' despite delayed irradiation for patients with small-
volume residual post-surgical disease. The morbidity of blad-
der dysfunction and the rate of deterioration of the upper
urinary tracts are, however, important considerations in a
conservative surgical policy which also involves
radiotherapy.
It is notable that the main bladder dysfunction in these
patients is reduced functional bladder capacity, usually with
normal compliance. Reduced compliance would be expected
if the dysfunction were caused by radiation-induced fibrosis.
Vale (1992) has recently demonstrated that, after irradiation,
rat bladders show a uniform delayed increase in purinergic
sensitivity and that fibrosis is not prominent. This observa-
tion suggests that a denervation hypersensitivity phenomenon
may contribute to the reduced functional capacity noted in
our study.
A high bladder salvage rate can be achieved in children
with pelvic RMS via a surgical policy aimed at bladder
conservation. Preservation of normal bladder function can be
achieved in some cases, and reconstruction of a compliant
urinary reservoir is made easier by the presence of a bladder,
because augmentation enterocystoplasty is a much easier pro-
cedure than the construction of a bladder de novo. In the
interval between tumour therapy and reconstructive surgery,
especially when radiotherapy has been used, the upper tractsBLADDER FUNCTION AFTER CHILDHOOD PELVIC SARCOMA 1003
may be at risk because of a small capacity and/or non-
compliant bladder. It is therefore imperative that these child-
ren have frequent long-term monitoring of function of the
bladder and upper urinary tracts. Assessment of the voiding
pattern using a frequency-volume chart is a cheap and
reliable method of detecting bladder dysfunction and helps to
select patients who require further investigation.
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